These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 1879975)

  • 21. Active rosette forming cells as a possible functional subpopulation of human peripheral T lymphocytes.
    Harada M; Ishino C; Mori T; Hattori K
    Jpn J Exp Med; 1977 Dec; 47(6):489-94. PubMed ID: 305494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. T acute lymphoblastic leukaemia with breast tumor. A brief report.
    Poros A; Hollán SR; Natonek K; Lelkes G; Gyódi E
    Haematologia (Budap); 1981; 14(2):215-8. PubMed ID: 6974118
    [TBL] [Abstract][Full Text] [Related]  

  • 23. "High-affinity" T-cell rosettes: the effects of clinical manipulations and potential prognostic significance.
    Weese JL; West WH; Herberman RB; Payne SM; Siwarski JW; Turcotte JG
    J Surg Oncol; 1980; 13(2):145-53. PubMed ID: 6965745
    [No Abstract]   [Full Text] [Related]  

  • 24. Double-rosetting technique for the detection of Fc gamma receptor-positive T lymphocytes.
    Cillari E; Di Gesu G; Palmeri S; Lio D; Salerno A; Li Voti P; La Via MF
    Diagn Immunol; 1983; 1(2):80-6. PubMed ID: 6238747
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Lymphoid cells in the venous blood of 100 female patients with breast carcinoma. Follow-up studies].
    Lellé RJ; Heidenreich W; Peter HH
    Onkologie; 1985 Aug; 8(4):241-5. PubMed ID: 3005936
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Disorders of the immune system in benign lesions and cancer of the breast].
    Derevnina NA; Polevaia EB; Veskova TK; Trubcheninova LP; Bogatyrev VN
    Vopr Onkol; 1989; 35(7):810-6. PubMed ID: 2788960
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Depression of 'high affinity' T-cell rosettes indicative of recurrent carcinoma.
    Weese J; West W; Herberman R; Turcotte JG
    Surg Forum; 1977; 28():155-7. PubMed ID: 310169
    [No Abstract]   [Full Text] [Related]  

  • 28. Rosetting of activated human T lymphocytes with autologous erythrocytes. Definition of the receptor and ligand molecules as CD2 and lymphocyte function-associated antigen 3 (LFA-3).
    Plunkett ML; Sanders ME; Selvaraj P; Dustin ML; Springer TA
    J Exp Med; 1987 Mar; 165(3):664-76. PubMed ID: 3102675
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Effect of therapy on the lymphoid cell distribution in the venous blood of breast cancer patients].
    Heidenreich W; Jagla K; Börner P; Peter HH; Deinhardt J; Deicher H
    Onkologie; 1979 Oct; 2(5):188-92. PubMed ID: 395474
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Effects of activated T cells on natural killing.
    Knight RA; Fitzharris P
    Immunology; 1982 Mar; 45(3):513-9. PubMed ID: 6174423
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Blood lymphocytes in infectious mononucleosis share the following characteristics with activated T cells: natural attachment, stable E rosetting and glucocorticoid sensitivity.
    Galili U; Seeley J; Svedmyr E; Klein E; Klein G; Weiland O
    J Clin Lab Immunol; 1980 May; 3(3):153-8. PubMed ID: 6968353
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Circulating T cells in patients with breast or genital cancers in the pre-therapeutic phase].
    Strache RR; Büttner HH; Kunze M; Röpcke G
    Zentralbl Gynakol; 1989; 111(12):816-23. PubMed ID: 2788342
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [A mathematical analysis of immunologic indicators in dyshormonal dysplasia and breast cancer].
    Zhalgasbaeva GT; Baisheva SA; Ozerova IV; Friazinova TS; Kuralasov AK
    Vopr Onkol; 1989; 35(10):1198-203. PubMed ID: 2596063
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mutual relationship between total and active T lymphocytes in patients with malignant tumors.
    Babusíková O; Babusík P; Novotná L
    Neoplasma; 1978; 25(1):67-74. PubMed ID: 305544
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Differentiation of lymphocyte populations in the blood of breast-cancer patients].
    Weber W; Nagel GA; Obrist R; Nagel E; Heitz P; Oberholzer M; Herzig D
    Schweiz Med Wochenschr; 1977 Jul; 107(28):1010-2. PubMed ID: 331468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The influence of autologous erythrocytes on active T-cells rosetting with sheep red blood cells and on DNA synthesis.
    Nowaczyk M; Skopińska-Rózewska E
    Arch Immunol Ther Exp (Warsz); 1981; 29(3):391-6. PubMed ID: 6975089
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The importance of dose of thymosin for the in vitro induction of T-lymphocytes from patients with solid tumours.
    Byrom NA; Retsas S; Dean AJ; Hobbs JR
    Clin Oncol; 1978 Mar; 4(1):25-34. PubMed ID: 305835
    [No Abstract]   [Full Text] [Related]  

  • 38. [Immunological profile of patients with neoplastic disease].
    Stivala F; Catania G; Basile F; Malaponte G; Bottiglieri C; Giovinetto A
    Minerva Chir; 1981 Mar; 36(5):297-302. PubMed ID: 6972495
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of spontaneous E-rosetting by antithymocyte globulin in Graves disease.
    Balázs C; Leövey A; Sztojka I; Szerze P; Szabó M; Bordán L; Fazakas S
    Acta Med Acad Sci Hung; 1976; 33(4):333-8. PubMed ID: 1088590
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Geographical distribution of Plasmodium falciparum erythrocyte rosetting and frequency of rosetting antibodies in human sera.
    Wahlgren M; Carlson J; Ruangjirachuporn W; Conway D; Helmby H; Martinez A; Patarroyo ME; Riley E
    Am J Trop Med Hyg; 1990 Oct; 43(4):333-8. PubMed ID: 2240361
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.